Clik here to view.
TROPION-Lung01 Head-to-Head Phase 3 Trial Initiated to Evaluate Datopotamab...
TOKYO & MUNICH & BASKING RIDGE, N.J. Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and AstraZeneca today announced the initiation of TROPION-Lung01, a global pivotal phase 3...
View ArticleClik here to view.
TROPION-Lung05 Phase 2 Trial of Datopotamab Deruxtecan Initiated in Patients...
TOKYO & MUNICH & BASKING RIDGE, N.J. Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and AstraZeneca today announced the initiation of TROPION-Lung05, a global phase 2 trial of...
View ArticleClik here to view.
Propanc Biopharma Provides Shareholder Update
MELBOURNE, Australia Propanc Biopharma, Inc. (OTC: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and...
View ArticleClik here to view.
研究人员采用Masimo ORi™（氧储备指数）帮助抑制乳房手术患者的术后高氧
瑞士纳沙泰尔 (美国商业资讯)–Masimo (NASDAQ: MASI)今天发布Euroanaesthesia 2020上最新呈报的一篇摘要的发现，该研究中，日本矢巾町岩手医科大学医院Kumagai博士及其同事调查Masimo ORi™（氧储备指数）能否用于限制术后高氧的程度1。研究人员的结论是，ORi可帮助“抑制高氧、预防缺氧”。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
武田薬品が2020年ASHで実臨床下の証拠を発表し、希少出血性疾患の個別化治療に対する長期的な傾倒ぶりを示す
米マサチューセッツ州ケンブリッジ & 大阪 （ビジネスワイヤ） — 武田薬品工業株式会社（TSE:...
View ArticleClik here to view.
研究者らがMasimo ORi™予備酸素摂量指数を乳房手術患者における術後酸素過剰状態の抑制に役立てる
スイス・ヌーシャテル （ビジネスワイヤ） — マシモ（NASDAQ: MASI）は本日、2020年欧州麻酔学会議で最近報告されたアブストラクトの知見を発表しました。本研究では矢巾町の岩手医科大学附属病院のKumagai医師と同僚らが、予備酸素摂量指数のMasimo ORi™が術後の酸素過剰状態の程度を制限するために使用できるか否かについて追究しました1。研究者らは、...
View ArticleClik here to view.
Digital Therapeutics Startup S-Alpha Therapeutics Raises $2.7M in Seed Funding
SEOUL On November 20th, S-Alpha Therapeutics (“S-Alpha” Seung Eun Choi, CEO), a digital therapeutics startup, completed a $2.7 Million USD (3 Billion KRW) seed round of funding from Hana Ventures,...
View ArticleClik here to view.
Bio-Thera Solutions Partners with Biomm to Market BAT1706 in Brazil
GUANGZHOU, China & SAO PAULO Bio-Thera Solutions (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and biosimilars, today announced the...
View ArticleClik here to view.
Alentis Founder Receives Prestigious French Academy of Science Award
BASEL, Switzerland Alentis Therapeutics, the Swiss biotech developing breakthrough treatments for fibrotic diseases, announced today that Prof. Thomas Baumert, its founder and world-leading...
View ArticleClik here to view.
Alentisの創設者が権威あるフランス科学アカデミー賞を受賞
スイス・バーゼル （ビジネスワイヤ） — 線維症の画期的な治療法を開発しているスイスのバイオテクノロジー企業であるAlentis Therapeuticsは本日、当社の創設者にして当分野の世界有数の権威であるトーマス・バウマート教授が、フランス科学アカデミー賞のMémain-Pelletierを受賞したと発表しました。これは肝がんの病因を理解するための画期的な研究が評価されての受賞となります。...
View ArticleClik here to view.
Alentis创始人荣获久负盛名的法兰西科学院奖
瑞士巴塞尔 (美国商业资讯)–开发纤维化疾病的突破性治疗药物的瑞士生物技术公司Alentis Therapeutics今天宣布，公司创始人、该领域世界领先的权威Thomas Baumert教授因其探寻肝癌发病机理的开创性研究而荣获法兰西科学院Mémain-Pelletier奖。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
InnoCare Announces the Approval of Orelabrutinib in China for Patients with...
BEIJING InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical company, announced today that its BTK inhibitor orelabrutinib received approval from the China National Medical Products...
View ArticleClik here to view.
Moderna Confirms 40 Million COVID-19 Vaccine Dose Supply Agreement with the...
CAMBRIDGE, Mass. Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today confirmed the Company has entered into a supply agreement with...
View ArticleClik here to view.
Guided Therapeutics Receives New Half Million Dollar Purchase Order from China
PEACHTREE CORNERS, Ga. Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva® Advanced Cervical Scan, based on its patented biophotonic technology, announced today that it had received a...
View ArticleClik here to view.
Genetron Health Announces Exclusive Strategic Partnership with Sino Biopharm...
NANJING, China Genetron Holdings Limited (“Genetron Health” or the “Company”) (Nasdaq: GTH), a leading precision oncology company in China that specializes in offering molecular profiling tests,...
View ArticleClik here to view.
Global Coalition for Adaptive Research, Kazia, and Kintara Announce...
LOS ANGELES Global Coalition for Adaptive Research (LOS ANGELES, CA), Kazia Therapeutics Limited (ASX: KZA, NASDAQ: KZIA, SYDNEY, Australia), and Kintara Therapeutics, Inc. (NASDAQ: KTRA, SAN DIEGO,...
View ArticleClik here to view.
PharmaEssentia Initiates Pivotal Trial of Ropeginterferon alfa-2b to Treat...
BURLINGTON, Mass. PharmaEssentia Corporation (TPEx: 6446), a global biopharmaceutical innovator leveraging deep expertise and proven scientific principles to deliver new biologics in hematology and...
View ArticleClik here to view.
LG Chem to Contribute to Global Polio Eradication with Eupolio™, the First...
SEOUL, South Korea LG Chem announced today that its Sabin-Inactivated Polio Vaccine (Sabin-IPV) Eupolio™ received World Health Organization (WHO) prequalification effective December 21st, 2020,...
View ArticleClik here to view.
Veristat Supported Marketing Applications for 10% of All FDA Novel Drug...
SOUTHBOROUGH, Mass. Veristat, a scientific-minded global clinical research organization (CRO), announced today that they supported the marketing applications for 10% of the 2020 US Food and Drug...
View ArticleClik here to view.
ARTMS和Telix Pharmaceuticals宣布利用从固态靶材通过回旋加速器产出的68Ga，成功生产出PSMA-11试剂盒
不列颠哥伦比亚省本拿比和印第安纳波利斯 (美国商业资讯)–ARTMS Inc. (“ARTMS”)和Telix Pharmaceuticals Limited (ASX: TLX, “Telix”)欣然宣布，他们通过ARTMS专有的Quantum Irradiation System (QIS®)固态靶材系统，使用由回旋加速器产出的多居里数量镓68...
View Article